科兴制药：2025年上半年净利润同比增长576.45%

Core Insights - The company reported a revenue of 700 million yuan for the first half of 2025, representing a year-on-year decrease of 7.82% [1] - The net profit reached 80.3445 million yuan, showing a significant year-on-year increase of 576.45% [1] - The basic earnings per share (EPS) was 0.41 yuan, which is an increase of 578.63% compared to the previous year [1]